https://hormones-inhibitors.co....m/dermatophytosis-to
Factors examined concerning CMV infection/disease included its incidence, recurrence, risk factors, mortality linked to CMV, treatment protocols and guidelines, resistant or refractory CMV, patient-reported outcomes, and the associated financial burden. From a group of 2708 analyzed studies, 49 were found eligible. Within these, 43 (87.8%) were in adults, and 34 (69.4%) were in kidney recipients (n=43/49; n=34/49).